ReviewJournal of clinical practice and research2024
Changing Epidemiology of Tuberculosis and Actions Taken in the World and Türkiye.
Review in Journal of clinical practice and research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) is an airborne, contagious illness caused by Mycobacterium tuberculosis, which can affect all tissues and organs, primarily the lungs. Tuberculosis remains a significant public health problem worldwide, with 10 million people contracting the disease and 1.5 million deaths annually. It is the second most common cause of death from communicable diseases globally, following Coronavirus Disease 2019 (COVID-19). To combat tuberculosis globally, the Global Tuberculosis Program is carried out by the World Health Organization (WHO). The WHO began the Directly Observed Treatment Strategy in 1995, the Stop Tuberculosis Strategy in 2006, and the End Tuberculosis Strategy in 2015. The End Tuberculosis Strategy aims to end the global tuberculosis epidemic by 2035. Due to the COVID-19 pandemic, global tuberculosis goals were missed or off-target. The fight against TB requires continuity. The National Tuberculosis Control Program, which includes the End Tuberculosis Strategy, has been implemented successfully for many years in alignment with global targets in Türkiye. In this article, the changing epidemiology of TB in the world and Türkiye is evaluated, and control activities carried out within the scope of combating TB are included.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.